Concepedia
Statistics
Publications
8
Citations
265
H-Index
Active since
2013
Affiliations
The University of Kansas Cancer Center(Current)
University of Kansas Medical Center
Fox Chase Cancer Center
Vanderbilt University Medical Center
Jeff Hirst is an author at The University of Kansas Cancer Center specializing in medicine, cancer biology, and oncology.
Top concepts
MedicineOncologyCancer BiologyCancer TherapyOvarian CancerGynecologyCell BiologyPharmacologyTumor BiologyRadiation Oncology
Publications per year
2013–2021
Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties
Jeff Hirst, Harsh B. Pathak, Stephen Hyter et al. · Cancer Research · 2018 · 49 citations · Full text
Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells
Thuy-Vy Do, Jeff Hirst, Stephen Hyter et al. · Oncotarget · 2017 · 44 citations · Full text
CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes
Shariska Petersen, Andrew J. Wilson, Jeff Hirst et al. · Gynecologic Oncology · 2020 · 40 citations · Full text
Drug Repurposing Identifies a Synergistic Combination Therapy with Imatinib Mesylate for Gastrointestinal Stromal Tumor
Ziyan Y. Pessetto, Yan Ma, Jeff Hirst et al. · Molecular Cancer Therapeutics · 2014 · 33 citations · Full text
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer
Vijayalaxmi Gupta, Jeff Hirst, Shariska Petersen et al. · Gynecologic Oncology · 2021 · 31 citations · Full text
Selective Hdac1/2 Inhibitor, Medicine, Pharmacology +7
1–5 of 8